atai Life Sciences Company, Perception Neuroscience,
Completed enrollment of Phase 2a proof-of-concept, randomized, double-blind, placebo-controlled clinical trial of PCN-101 (R-ketamine).Last patient...
Source: globenewswire.com
Page 2 - Modified Observer News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Modified Observer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Modified Observer Today - Breaking & Trending Today
Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences Company, Perception Neuroscience, Completes Enrollment for Phase 2a Clinical Trial of PCN-101 (R-Ketamine) for Treatment-Resistant Depression
Investegate announcements from atai Life Sciences, atai Life Sciences Company, Perception Neuroscience, Completes Enrollment for Phase 2a Clinical Trial of PCN-101 (R-Ketamine) for Treatment-Resistant Depression
Source: investegate.co.uk
atai Life Sciences Company, Perception Neuroscience, Completes Enrollment for Phase 2a Clinical Trial of PCN-101 (R-Ketamine) for Treatment-Resistant Depression
Completed enrollment of Phase 2a proof-of-concept, randomized, double-blind, placebo-controlled clinical trial of PCN-101 (R-ketamine).Last patient expected to be dosed this week, with the total number
Source: finanznachrichten.de